Product Details for ANDA 202595
OSELTAMIVIR PHOSPHATE (OSELTAMIVIR PHOSPHATE)
EQ 30MG BASE
Marketing Status: Prescription
EQ 45MG BASE
Marketing Status: Prescription
EQ 75MG BASE
Marketing Status: Prescription
EQ 30MG BASE
Marketing Status: Prescription
Active Ingredient: OSELTAMIVIR PHOSPHATE
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 001
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
OSELTAMIVIR PHOSPHATE (OSELTAMIVIR PHOSPHATE)
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 001
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 45MG BASE
Marketing Status: Prescription
Active Ingredient: OSELTAMIVIR PHOSPHATE
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 45MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 002
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
OSELTAMIVIR PHOSPHATE (OSELTAMIVIR PHOSPHATE)
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 45MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 002
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: OSELTAMIVIR PHOSPHATE
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 003
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: OSELTAMIVIR PHOSPHATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202595
Product Number: 003
Approval Date: Aug 3, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information